Cargando…
Corrigendum to “Serglycin‐induced interleukin‐1β from oesophageal cancer cells upregulate hepatocyte growth factor in fibroblasts topromote tumour angiogenesis and growth”
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869645/ https://www.ncbi.nlm.nih.gov/pubmed/36688488 http://dx.doi.org/10.1002/ctm2.1185 |
| _version_ | 1784876812251168768 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9869645 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98696452023-01-25 Corrigendum to “Serglycin‐induced interleukin‐1β from oesophageal cancer cells upregulate hepatocyte growth factor in fibroblasts topromote tumour angiogenesis and growth” Clin Transl Med Corrigendum John Wiley and Sons Inc. 2023-01-23 /pmc/articles/PMC9869645/ /pubmed/36688488 http://dx.doi.org/10.1002/ctm2.1185 Text en © 2023 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Corrigendum Corrigendum to “Serglycin‐induced interleukin‐1β from oesophageal cancer cells upregulate hepatocyte growth factor in fibroblasts topromote tumour angiogenesis and growth” |
| title | Corrigendum to “Serglycin‐induced interleukin‐1β from oesophageal cancer cells upregulate hepatocyte growth factor in fibroblasts topromote tumour angiogenesis and growth” |
| title_full | Corrigendum to “Serglycin‐induced interleukin‐1β from oesophageal cancer cells upregulate hepatocyte growth factor in fibroblasts topromote tumour angiogenesis and growth” |
| title_fullStr | Corrigendum to “Serglycin‐induced interleukin‐1β from oesophageal cancer cells upregulate hepatocyte growth factor in fibroblasts topromote tumour angiogenesis and growth” |
| title_full_unstemmed | Corrigendum to “Serglycin‐induced interleukin‐1β from oesophageal cancer cells upregulate hepatocyte growth factor in fibroblasts topromote tumour angiogenesis and growth” |
| title_short | Corrigendum to “Serglycin‐induced interleukin‐1β from oesophageal cancer cells upregulate hepatocyte growth factor in fibroblasts topromote tumour angiogenesis and growth” |
| title_sort | corrigendum to “serglycin‐induced interleukin‐1β from oesophageal cancer cells upregulate hepatocyte growth factor in fibroblasts topromote tumour angiogenesis and growth” |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869645/ https://www.ncbi.nlm.nih.gov/pubmed/36688488 http://dx.doi.org/10.1002/ctm2.1185 |